HTA2 Cost-Effectiveness of a Clinical Care Pathway for the Screening of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1687
https://www.valueinhealthjournal.com/article/S1098-3015(23)04817-9/fulltext
Title :
HTA2 Cost-Effectiveness of a Clinical Care Pathway for the Screening of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04817-9&doi=10.1016/j.jval.2023.09.1687
First page :
Section Title :
Open access? :
No
Section Order :
11135